CLINICAL_TRIALS
trial_result
· 2016-08-04
Clinical Trial Update: A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas [Phase 2]
Summary
Phase 2 trial update evaluating two vismodegib regimens in participants with multiple basal cell carcinomas; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-04